Hos patienter, der udvikler trombocytopeni, d. v. s. trombocyttal som konstant ligger under 100. 000/ mm3, bør intermitterende behandling eller dosisnedsættelse overvejes.
Consideration should be given to intermittent cessation or decreasing the dose of filgrastim in patients who develop thrombocytopenia, i. e. platelets consistently < 100,000/ mm3.